Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Laura Faden Garabedian, Ph.D.

Concepts (119)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Comparative Effectiveness Research320226811.280 Why?
Deductibles and Coinsurance220213160.830 Why?
Diabetes Mellitus5202156620.760 Why?
Insurance, Health4202024920.660 Why?
Blood Glucose Self-Monitoring120194150.560 Why?
Bariatric Surgery120229290.440 Why?
Telemedicine2201928020.370 Why?
Insurance Coverage2202018890.340 Why?
Drug Approval520107400.340 Why?
Insurance, Pharmaceutical Services320103360.310 Why?
Quality Assurance, Health Care1201822220.310 Why?
Health Care Reform1201612600.290 Why?
Patient Acceptance of Health Care2201929950.280 Why?
Quality of Health Care2201843690.280 Why?
Blood Glucose1201962290.250 Why?
Attitude of Health Personnel1201838440.250 Why?
Insurance, Health, Reimbursement220093980.240 Why?
Product Surveillance, Postmarketing220094550.240 Why?
Research Personnel120085690.220 Why?
Formularies as Topic32009910.210 Why?
Tobacco, Smokeless120231290.210 Why?
Primary Health Care1201845310.210 Why?
Interviews as Topic2201825300.200 Why?
Medical Savings Accounts12020320.190 Why?
Minority Groups1200811850.180 Why?
Drug Utilization Review120112450.180 Why?
Cost Sharing220204070.170 Why?
Economic Competition120102130.170 Why?
Government Programs120112740.170 Why?
Insurance Carriers120201470.170 Why?
Patient Protection and Affordable Care Act2202012050.160 Why?
Intrauterine Devices120191180.160 Why?
Off-Label Use120091690.150 Why?
Drug Industry220107440.150 Why?
Eligibility Determination120204010.140 Why?
Influenza Vaccines120237480.140 Why?
Costs and Cost Analysis1202116730.130 Why?
New England1201810150.130 Why?
Health Services120117590.130 Why?
Patient Selection1200842220.130 Why?
Drug Design1201010940.130 Why?
Internationality2200810040.130 Why?
Pharmacoepidemiology120083250.120 Why?
Burnout, Professional120236810.120 Why?
Risk Management120085730.120 Why?
Focus Groups1201812970.120 Why?
Influenza, Human1202314840.110 Why?
Humans2420247369400.110 Why?
Program Evaluation1201124840.100 Why?
Research Design1200859650.100 Why?
Pharmaceutical Preparations2201010650.100 Why?
Insurance Claim Review120167250.100 Why?
Drug Monitoring120089500.100 Why?
International Cooperation1200814230.100 Why?
Equipment Design1201935660.100 Why?
Self Care120157880.090 Why?
Students, Medical1202318430.090 Why?
Qualitative Research1201826390.090 Why?
United States Food and Drug Administration4201015850.090 Why?
Health Services Accessibility2200751150.080 Why?
Health Expenditures1202123510.080 Why?
Poverty1202026210.080 Why?
Developing Countries1201027620.080 Why?
United States82020693620.080 Why?
Hypoglycemic Agents1202028410.080 Why?
Quality Indicators, Health Care1201818360.080 Why?
Antipsychotic Agents1201130460.080 Why?
Drug Prescriptions1200716340.070 Why?
Massachusetts2201986690.070 Why?
Regression Analysis1201464320.060 Why?
Prejudice120085690.060 Why?
Socioeconomic Factors1201677150.050 Why?
Schizophrenia1201168480.050 Why?
Time Factors32016401310.050 Why?
Patents as Topic120101000.040 Why?
Immunotherapy1200543500.040 Why?
Middle Aged420202131150.040 Why?
Antibodies, Monoclonal1200592730.040 Why?
Data Collection1200833470.040 Why?
Cardiovascular Diseases12024149680.040 Why?
Aged220211626790.040 Why?
Financing, Personal120203090.040 Why?
Pharmacopoeias as Topic12007170.040 Why?
Follow-Up Studies12019389370.040 Why?
European Union120081570.040 Why?
Clinical Trials as Topic2200878710.040 Why?
Female620203785100.040 Why?
Pharmacy and Therapeutics Committee1200690.040 Why?
Male520203490250.030 Why?
Longitudinal Studies22023138370.030 Why?
Cost-Benefit Analysis2201053590.030 Why?
France120075160.030 Why?
Government Agencies120061570.030 Why?
Adolescent32020852250.030 Why?
Chemistry, Pharmaceutical120052830.030 Why?
Hybridomas120054510.030 Why?
State Medicine120062170.030 Why?
Marketing120062090.030 Why?
Japan1200813460.030 Why?
Pandemics2202481680.030 Why?
Biotechnology120052720.030 Why?
Government Regulation120085220.030 Why?
Safety1200811900.030 Why?
Netherlands1200721670.030 Why?
Vaccination1202332110.020 Why?
Adult320202132830.020 Why?
Emotions1202326210.020 Why?
Retrospective Studies12019762000.020 Why?
Reimbursement Mechanisms120066710.020 Why?
Physicians1200845200.020 Why?
Medicare2200964400.020 Why?
Patient Participation1200714360.020 Why?
Evidence-Based Medicine1200936130.020 Why?
Anxiety1201942170.020 Why?
Child22023767000.010 Why?
Young Adult22020562390.010 Why?
Health Care Costs1200731950.010 Why?
Neoplasms12005214100.000 Why?
Animals120051687350.000 Why?
Garabedian's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (119)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.